OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapies targeting tumor vasculature: challenges and opportunities
Hassan Dianat‐Moghadam, Reza Nedaeinia, Mohsen Keshavarz, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14

Showing 14 citing articles:

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 12

CAR-T cell therapy for hepatocellular carcinoma: current trends and challenges
Yexin Zhou, Shanshan Wei, Meng-Hui Xu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6

Microwave-Orchestrated Phototherapeutic Polypyrrole/Soy Extraction Micro-complex for Burn Wound Healing in A Rodent Model
Shen-Han Wu, Hsien‐Tsung Lu, Hieu Trung Nguyen, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106911-106911
Closed Access

Anlotinib and anti-PD-1 mAbs perfected CIK cell therapy for lung adenocarcinoma in preclinical trials
Yingge Lv, Hua Zhao, Shaochuan Liu, et al.
Journal of Leukocyte Biology (2024) Vol. 116, Iss. 3, pp. 544-554
Open Access | Times Cited: 2

Group XIV C-type lectins: emerging targets in tumor angiogenesis
Elliott J. Yee, Isaac Vigil, Yi Sun, et al.
Angiogenesis (2024) Vol. 27, Iss. 2, pp. 173-192
Open Access | Times Cited: 2

An overview of the regulatory role of annexin A1 in the tumor microenvironment and its prospective clinical application (Review)
Kuan Gao, Xinyang Li, Shuya Luo, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 5
Open Access | Times Cited: 2

NK Cell‐Based Cancer Immunotherapies: Current Progress, Challenges and Emerging Opportunities
Mohammad Y. Alshahrani, Subasini Uthirapathy, Abhinav Kumar, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 11
Closed Access | Times Cited: 2

Nanotechnology and Immunetherapy: reduction of hepatotoxicity and anti-antineoplastic efficiency
Irami Araújo-Filho, Amália Cínthia Meneses do Rêgo
JOURNAL OF SURGICAL AND CLINICAL RESEARCH (2024) Vol. 15, Iss. 1, pp. 59-78
Open Access | Times Cited: 1

CAR T cells in solid tumors and metastasis: paving the way forward
Camilla Sirini, Laura Rossi, Marta Angiola Moresco, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 4, pp. 1279-1296
Closed Access | Times Cited: 1

Tumor cavitation in patients with non-small-cell lung cancer receiving anti-angiogenic therapy with apatinib
Qian Cai, Kui Hu, Shuang Dong, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 7, pp. 1708-1717
Open Access

Nanocarrier Design Based on the Tumor Microenvironment Target: A Pivotal Direction in Nano-Drug Delivery Strategies
Zirui Zhang, Xinyuan Kong, Zhijie Wang, et al.
Diseases & Research (2024) Vol. 4, pp. 1-8
Closed Access

The role of N6-methyladenosine modification in tumor angiogenesis
Qin Li, Xinya Zeng, Xinze Qiu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access

Page 1

Scroll to top